Getting a grip can be difficult for patients with rheumatoid arthritis or psoriatic arthritis. Yet, when we examined biologic administration devices, it seemed that an ordinary bike handle had a leg up in terms of ergonomic design. How are patients supposed to administer their medicine when they struggle to grasp their injection device? A design team looked into the ergonomics.
Syringes have continued to evolve over the centuries. Once an experimental surgical procedure, injections are now routinely performed at home by patients. So, we asked ourselves how today’s technology might help change the patient injection process.
Do you ever wonder how patients are really doing outside of office visits? Some patients document their experiences by tracking their health in a journal or a mobile app. But often, the information isn’t conveyed well or even at all during an office visit. We wanted to find a convenient way for patients to consistently collect information about key signs and symptoms and easily share it with their physicians.
Watching an airplane take flight looks easy and smooth. It's actually a meticulous science based on accurate and consistent measurements. Combustors precisely regulate the fuel injection rate to help maintain a controlled and consistent propulsion during flight. Similarly, the self-injection process aims to bring a consistent and controlled experience. Our device engineers explored the operational components.
Sometimes, revisiting the science and challenging old assumptions can bring new understanding to what was once ambiguous. For patients with psoriatic arthritis, we thought there were still many open questions. We wanted to reevaluate how best to treat psoriatic arthritis, so we set out to develop a new clinical trial.
Try. Test. Tweak. Repeat. Methodical experimentation, collaboration, and refinement have long been critical to the process of innovation.
Based on these methods, the history of progress has steadily advanced by humanity’s urge to never settle for “good enough,” like exploring ways to efficiently produce food that serves more people or finding smarter ways to help golfers better their game.
It’s in that spirit that we continually work toward uncovering the potential of proven moderate to severe rheumatoid arthritis (RA) and psoriatic arthritis (PsA) therapies.
For patients with moderate to severe RA, the passage of time often brings change—both to their lives as well as their state of disease. And just as patients adapt to these changes, their rheumatologists monitor and evaluate whether their treatment plan can be adjusted to better fit their needs. Recognizing the chronic nature of RA, we sought clinical evidence to support rheumatologists as they adapt treatments within the dynamic nature of patient management.